US Stock MarketDetailed Quotes

ATNF 180 Life Sciences

Watchlist
  • 2.250
  • -0.030-1.32%
Close Nov 22 16:00 ET
  • 2.330
  • +0.080+3.56%
Post 20:01 ET
4.45MMarket Cap-740P/E (TTM)

180 Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
87.40%-223.66K
123.33%727.17K
73.30%-1.03M
9.94%-10.92M
26.20%-2.16M
50.63%-1.78M
11.74%-3.12M
-86.69%-3.87M
37.39%-12.13M
41.79%-2.93M
Net income from continuing operations
91.85%-836.72K
100.32%11.78K
77.54%-1.07M
48.52%-19.94M
94.36%-1.23M
52.22%-10.27M
-225.21%-3.68M
-404.54%-4.76M
-90.54%-38.73M
-2,198.24%-21.74M
Operating gains losses
--0
98.27%-249
100.36%191
99.50%-75.32K
99.43%-5.55K
99.86%-2.04K
99.81%-14.42K
98.98%-53.32K
-386.23%-15.14M
82.75%-977.43K
Depreciation and amortization
-57.63%13.85K
-16.00%23.98K
8.29%23.58K
-3.05%105.68K
-39.75%22.66K
309.99%32.69K
-22.75%28.55K
-17.72%21.77K
-0.86%109K
123.75%37.61K
Deferred tax
----
----
----
-149.24%-2.35M
99.51%-4.66K
----
----
----
-3,700.95%-942.75K
-11,374.55%-942.75K
Other non cash items
---37.28K
----
----
----
----
----
----
----
----
----
Change In working capital
-43.48%620.04K
39,149.01%826.28K
-161.01%-223.5K
-100.52%-14.1K
-174.13%-1.48M
616.53%1.1M
-102.51%-2.12K
-57.44%366.32K
130.91%2.72M
242.17%1.99M
-Change in prepaid assets
-0.74%206.89K
18.19%756.05K
13.09%480.53K
-66.88%337.28K
-195.29%-935.75K
117.79%208.43K
140.76%639.69K
230.72%424.91K
173.94%1.02M
205.17%981.96K
-Change in payables and accrued expense
-53.51%413.15K
110.94%70.23K
-1,101.51%-704.04K
-120.62%-351.39K
-153.52%-539.59K
388.42%888.61K
-253.68%-641.81K
-104.94%-58.6K
122.94%1.7M
316.29%1.01M
Cash from discontinued investing activities
Operating cash flow
87.40%-223.66K
123.33%727.17K
73.30%-1.03M
9.94%-10.92M
26.20%-2.16M
50.63%-1.78M
11.74%-3.12M
-86.69%-3.87M
37.39%-12.13M
41.79%-2.93M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-119.45%-476.07K
-110.76%-264.91K
43.72%-264.39K
-45.67%5.91M
-77.04%1.47M
-55.41%2.45M
598.09%2.46M
8.85%-469.81K
-57.21%10.87M
312.88%6.4M
Net issuance payments of debt
-84.78%-476.07K
-2.78%-264.91K
43.62%-264.88K
52.89%-288.07K
-20.83%697.11K
46.57%-257.63K
47.86%-257.73K
8.85%-469.81K
-176.35%-611.42K
-43.15%880.56K
Net common stock issuance
--0
----
----
-47.76%6M
--0
665.98%3M
----
----
-56.93%11.48M
--12.01M
Proceeds from stock option exercised by employees
--0
--0
--489
23.97%512
100.01%329
-100.00%66
--117
--0
--413
---6.5M
Net other financing activities
----
----
----
--195.95K
--770.92K
---294.98K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-119.45%-476.07K
-110.76%-264.91K
43.72%-264.39K
-45.67%5.91M
-77.04%1.47M
-55.41%2.45M
598.09%2.46M
8.85%-469.81K
-57.21%10.87M
312.88%6.4M
Net cash flow
Beginning cash position
-42.93%1.15M
-74.45%675.98K
-71.65%1.98M
-15.25%6.97M
-25.81%2.66M
23.59%2.01M
-53.32%2.65M
-15.25%6.97M
290.06%8.22M
-69.30%3.59M
Current changes in cash
-204.19%-699.72K
170.62%462.26K
70.09%-1.3M
-299.87%-5.01M
-119.94%-691.65K
-64.49%671.59K
83.74%-654.57K
-67.66%-4.34M
-120.76%-1.25M
199.73%3.47M
Effect of exchange rate changes
-1,323.89%-251.64K
-52.63%8.05K
-112.75%-2.01K
4,879.24%20.03K
105.64%4.93K
-124.52%-17.67K
195.47%16.99K
-51.84%15.78K
-100.56%-419
-675.75%-87.46K
End cash Position
-92.68%194.92K
-42.93%1.15M
-74.45%675.98K
-71.65%1.98M
-71.65%1.98M
-25.81%2.66M
23.59%2.01M
-53.32%2.65M
-15.25%6.97M
-15.25%6.97M
Free cash flow
87.40%-223.66K
123.33%727.17K
73.30%-1.03M
9.94%-10.92M
26.20%-2.16M
50.63%-1.78M
11.74%-3.12M
-86.69%-3.87M
37.39%-12.13M
41.79%-2.93M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 87.40%-223.66K123.33%727.17K73.30%-1.03M9.94%-10.92M26.20%-2.16M50.63%-1.78M11.74%-3.12M-86.69%-3.87M37.39%-12.13M41.79%-2.93M
Net income from continuing operations 91.85%-836.72K100.32%11.78K77.54%-1.07M48.52%-19.94M94.36%-1.23M52.22%-10.27M-225.21%-3.68M-404.54%-4.76M-90.54%-38.73M-2,198.24%-21.74M
Operating gains losses --098.27%-249100.36%19199.50%-75.32K99.43%-5.55K99.86%-2.04K99.81%-14.42K98.98%-53.32K-386.23%-15.14M82.75%-977.43K
Depreciation and amortization -57.63%13.85K-16.00%23.98K8.29%23.58K-3.05%105.68K-39.75%22.66K309.99%32.69K-22.75%28.55K-17.72%21.77K-0.86%109K123.75%37.61K
Deferred tax -------------149.24%-2.35M99.51%-4.66K-------------3,700.95%-942.75K-11,374.55%-942.75K
Other non cash items ---37.28K------------------------------------
Change In working capital -43.48%620.04K39,149.01%826.28K-161.01%-223.5K-100.52%-14.1K-174.13%-1.48M616.53%1.1M-102.51%-2.12K-57.44%366.32K130.91%2.72M242.17%1.99M
-Change in prepaid assets -0.74%206.89K18.19%756.05K13.09%480.53K-66.88%337.28K-195.29%-935.75K117.79%208.43K140.76%639.69K230.72%424.91K173.94%1.02M205.17%981.96K
-Change in payables and accrued expense -53.51%413.15K110.94%70.23K-1,101.51%-704.04K-120.62%-351.39K-153.52%-539.59K388.42%888.61K-253.68%-641.81K-104.94%-58.6K122.94%1.7M316.29%1.01M
Cash from discontinued investing activities
Operating cash flow 87.40%-223.66K123.33%727.17K73.30%-1.03M9.94%-10.92M26.20%-2.16M50.63%-1.78M11.74%-3.12M-86.69%-3.87M37.39%-12.13M41.79%-2.93M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -119.45%-476.07K-110.76%-264.91K43.72%-264.39K-45.67%5.91M-77.04%1.47M-55.41%2.45M598.09%2.46M8.85%-469.81K-57.21%10.87M312.88%6.4M
Net issuance payments of debt -84.78%-476.07K-2.78%-264.91K43.62%-264.88K52.89%-288.07K-20.83%697.11K46.57%-257.63K47.86%-257.73K8.85%-469.81K-176.35%-611.42K-43.15%880.56K
Net common stock issuance --0---------47.76%6M--0665.98%3M---------56.93%11.48M--12.01M
Proceeds from stock option exercised by employees --0--0--48923.97%512100.01%329-100.00%66--117--0--413---6.5M
Net other financing activities --------------195.95K--770.92K---294.98K----------------
Cash from discontinued financing activities
Financing cash flow -119.45%-476.07K-110.76%-264.91K43.72%-264.39K-45.67%5.91M-77.04%1.47M-55.41%2.45M598.09%2.46M8.85%-469.81K-57.21%10.87M312.88%6.4M
Net cash flow
Beginning cash position -42.93%1.15M-74.45%675.98K-71.65%1.98M-15.25%6.97M-25.81%2.66M23.59%2.01M-53.32%2.65M-15.25%6.97M290.06%8.22M-69.30%3.59M
Current changes in cash -204.19%-699.72K170.62%462.26K70.09%-1.3M-299.87%-5.01M-119.94%-691.65K-64.49%671.59K83.74%-654.57K-67.66%-4.34M-120.76%-1.25M199.73%3.47M
Effect of exchange rate changes -1,323.89%-251.64K-52.63%8.05K-112.75%-2.01K4,879.24%20.03K105.64%4.93K-124.52%-17.67K195.47%16.99K-51.84%15.78K-100.56%-419-675.75%-87.46K
End cash Position -92.68%194.92K-42.93%1.15M-74.45%675.98K-71.65%1.98M-71.65%1.98M-25.81%2.66M23.59%2.01M-53.32%2.65M-15.25%6.97M-15.25%6.97M
Free cash flow 87.40%-223.66K123.33%727.17K73.30%-1.03M9.94%-10.92M26.20%-2.16M50.63%-1.78M11.74%-3.12M-86.69%-3.87M37.39%-12.13M41.79%-2.93M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data